Inogen (INGN) Other Non-Current Liabilities (2013 - 2026)
Inogen (INGN) posted quarterly Other Non-Current Liabilities of $18.4 million for Q1 2026, up 13.32% year-over-year from $16.2 million in Q1 2025, and up 1.07% quarter-over-quarter from $18.2 million in Q4 2025.
Inogen (INGN) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Other Non-Current Liabilities for 14 consecutive years, with $18.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 13.32% year-over-year to $18.4 million; the TTM figure through Mar 2026 stood at $18.4 million (up 13.32% YoY), while the FY2025 annual figure was $18.2 million, up 39.95% from the prior year.
- Other Non-Current Liabilities advanced to $18.4 million in Q1 2026 per INGN's latest filing, from $18.2 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $18.4 million in Q1 2026 and bottomed at $3.2 million in Q3 2023.
- Historically, Other Non-Current Liabilities has averaged $12.6 million across 5 years, with a median of $12.6 million in 2023.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities slumped 58.35% — and 2024, when it surged 409.22%.
- Inogen's Other Non-Current Liabilities stood at $12.1 million in 2022, then increased by 14.25% to $13.8 million in 2023, then fell by 6.14% to $13.0 million in 2024, then surged by 39.95% to $18.2 million in 2025, then gained by 1.07% to $18.4 million in 2026.
- Business Quant data shows INGN's Other Non-Current Liabilities at $18.4 million in Q1 2026, $18.2 million in Q4 2025, and $17.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.96 Mn |
| Mar 31, 2026 | 18.39 Mn |
| Dec 31, 2025 | 18.19 Mn |
| Sep 30, 2025 | 17.82 Mn |
| Jun 30, 2025 | 16.99 Mn |
| Mar 31, 2025 | 16.23 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Sep 30, 2024 | 16.18 Mn |
| Jun 30, 2024 | 11.18 Mn |
| Mar 31, 2024 | 10.57 Mn |
| Dec 31, 2023 | 13.85 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 12.60 Mn |
| Mar 31, 2023 | 12.02 Mn |
| Dec 31, 2022 | 12.12 Mn |
| Sep 30, 2022 | 7.63 Mn |
| Jun 30, 2022 | 7.14 Mn |
| Mar 31, 2022 | 6.57 Mn |
| Dec 31, 2021 | 7.25 Mn |
| Sep 30, 2021 | 8.61 Mn |